These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 35210989)

  • 61. Progress of RAGE Molecular Imaging in Alzheimer's Disease.
    Kong Y; Liu C; Zhou Y; Qi J; Zhang C; Sun B; Wang J; Guan Y
    Front Aging Neurosci; 2020; 12():227. PubMed ID: 32848706
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer.
    Fodero-Tavoletti MT; Brockschnieder D; Villemagne VL; Martin L; Connor AR; Thiele A; Berndt M; McLean CA; Krause S; Rowe CC; Masters CL; Dinkelborg L; Dyrks T; Cappai R
    Nucl Med Biol; 2012 Oct; 39(7):1042-8. PubMed ID: 22503458
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preclinical Evaluation of [(18)F]THK-5105 Enantiomers: Effects of Chirality on Its Effectiveness as a Tau Imaging Radiotracer.
    Tago T; Furumoto S; Okamura N; Harada R; Adachi H; Ishikawa Y; Yanai K; Iwata R; Kudo Y
    Mol Imaging Biol; 2016 Apr; 18(2):258-66. PubMed ID: 26194011
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Exploring the Role of Monoamine Oxidase Activity in Aging and Alzheimer's Disease.
    Rahman MS; Uddin MS; Rahman MA; Samsuzzaman M; Behl T; Hafeez A; Perveen A; Barreto GE; Ashraf GM
    Curr Pharm Des; 2021; 27(38):4017-4029. PubMed ID: 34126892
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque.
    Holland JP; Liang SH; Rotstein BH; Collier TL; Stephenson NA; Greguric I; Vasdev N
    J Labelled Comp Radiopharm; 2014 Apr; 57(4):323-31. PubMed ID: 24327420
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.
    Lemoine L; Gillberg PG; Svedberg M; Stepanov V; Jia Z; Huang J; Nag S; Tian H; Ghetti B; Okamura N; Higuchi M; Halldin C; Nordberg A
    Alzheimers Res Ther; 2017 Dec; 9(1):96. PubMed ID: 29229003
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography.
    Wang YT; Edison P
    Curr Neurol Neurosci Rep; 2019 Jun; 19(7):45. PubMed ID: 31172290
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structure-Activity Relationship of 2-Arylquinolines as PET Imaging Tracers for Tau Pathology in Alzheimer Disease.
    Tago T; Furumoto S; Okamura N; Harada R; Adachi H; Ishikawa Y; Yanai K; Iwata R; Kudo Y
    J Nucl Med; 2016 Apr; 57(4):608-14. PubMed ID: 26697966
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
    Whitwell JL; Ahlskog JE; Tosakulwong N; Senjem ML; Spychalla AJ; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.
    Vallabhajosula S
    Semin Nucl Med; 2011 Jul; 41(4):283-99. PubMed ID: 21624562
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm.
    Chiotis K; Saint-Aubert L; Savitcheva I; Jelic V; Andersen P; Jonasson M; Eriksson J; Lubberink M; Almkvist O; Wall A; Antoni G; Nordberg A
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1686-99. PubMed ID: 26996778
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Relationship between the temporal course of astrogliosis and symptom improvement in cerebral infarction: report of a case monitored using
    Ishibashi K; Miura Y; Hirata K; Toyohara J; Ishii K
    BMC Med Imaging; 2020 Jul; 20(1):81. PubMed ID: 32664871
    [TBL] [Abstract][Full Text] [Related]  

  • 73.
    Park S; Oh M; Kim JS; Lee JH; Yoon YW; Roh JH
    Brain Sci; 2021 Apr; 11(4):. PubMed ID: 33917613
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    Kroth H; Oden F; Molette J; Schieferstein H; Gabellieri E; Mueller A; Berndt M; Sreenivasachary N; Serra AM; Capotosti F; Schmitt-Willich H; Hickman D; Pfeifer A; Dinkelborg L; Stephens A
    J Med Chem; 2021 Sep; 64(17):12808-12830. PubMed ID: 34455780
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms.
    Lyoo CH; Cho H; Choi JY; Ryu YH; Lee MS
    J Mov Disord; 2018 Jan; 11(1):1-12. PubMed ID: 29381890
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Amyloid-Beta Positron Emission Tomography Imaging of Alzheimer's Pathology in Parkinson's Disease Dementia.
    Akhtar RS; Xie SX; Brennan L; Pontecorvo MJ; Hurtig HI; Trojanowski JQ; Weintraub D; Siderowf AD
    Mov Disord Clin Pract; 2016; 3(4):367-375. PubMed ID: 27500181
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preclinical Evaluation of
    Declercq L; Rombouts F; Koole M; Fierens K; Mariën J; Langlois X; Andrés JI; Schmidt M; Macdonald G; Moechars D; Vanduffel W; Tousseyn T; Vandenberghe R; Van Laere K; Verbruggen A; Bormans G
    J Nucl Med; 2017 Jun; 58(6):975-981. PubMed ID: 28232614
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of [
    Kramer V; Brooks AF; Haeger A; Kuljis RO; Rafique W; Koeppe RA; Raffel DM; Frey KA; Amaral H; Scott PJH; Riss PJ
    ACS Chem Neurosci; 2020 Feb; 11(3):427-435. PubMed ID: 31898886
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease.
    Li Y; Tsui W; Rusinek H; Butler T; Mosconi L; Pirraglia E; Mozley D; Vallabhajosula S; Harada R; Furumoto S; Furukawa K; Arai H; Kudo Y; Okamura N; de Leon MJ
    J Nucl Med; 2015 Feb; 56(2):270-3. PubMed ID: 25572087
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of [
    Tezuka T; Takahata K; Seki M; Tabuchi H; Momota Y; Shiraiwa M; Suzuki N; Morimoto A; Nakahara T; Iwabuchi Y; Miura E; Yamamoto Y; Sano Y; Funaki K; Yamagata B; Ueda R; Yoshizaki T; Mashima K; Shibata M; Oyama M; Okada K; Kubota M; Okita H; Takao M; Jinzaki M; Nakahara J; Mimura M; Ito D
    Brain Commun; 2021; 3(4):fcab190. PubMed ID: 34632382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.